{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:40:08Z","timestamp":1774438808007,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.lpm.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T19:29:40Z","timestamp":1533842980000},"page":"e109-e118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"P2","title":["Pheochromocytoma: When to search a germline defect?"],"prefix":"10.1016","volume":"47","author":[{"given":"Alexandre","family":"Buffet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.07.003_bib0325","series-title":"Pathology and genetics of tumours of endocrine organs. World Health Organization classification of tumours","year":"2004"},{"key":"10.1016\/j.lpm.2018.07.003_bib0330","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"International symposium on pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0340","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0345","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.lpm.2018.07.003_bib0350","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0355","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0365","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lpm.2018.07.003_bib0370","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.lpm.2018.07.003_bib0380","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis Bethesda, Md., USA, July 13\u201315, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.lpm.2018.07.003_bib0385","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2018.07.003_bib0390","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0395","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2018.07.003_bib0400","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cen.13265","article-title":"Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1","volume":"86","author":"Moramarco","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2018.07.003_bib0405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0410","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"5","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lpm.2018.07.003_bib0420","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000345667","article-title":"Multiple endocrine neoplasia type 2","volume":"41","author":"Lodish","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0430","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2018.07.003_bib0435","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0440","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.lpm.2018.07.003_bib0445","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s004390050939","article-title":"Repositioning the hereditary paraganglioma critical region on chromosome band 11q23","volume":"104","author":"Baysal","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0450","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lpm.2018.07.003_bib0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0460","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0465","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0470","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3390\/metabo7020017","article-title":"Mitochondrial deficiencies in the predisposition to paraganglioma","volume":"7","author":"Lussey-Lepoutre","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.lpm.2018.07.003_bib0475","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lpm.2018.07.003_bib0480","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.lpm.2018.07.003_bib0485","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.lpm.2018.07.003_bib0490","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1210\/jc.2002-020525","article-title":"Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma","volume":"87","author":"Gimenez-Roqueplo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0495","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0500","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0505","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.anorl.2012.04.007","article-title":"The genetics of paragangliomas","volume":"129","author":"Burnichon","year":"2012","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.lpm.2018.07.003_bib0510","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","author":"Killian","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.lpm.2018.07.003_bib0515","doi-asserted-by":"crossref","first-page":"268ra177","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","author":"Killian","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lpm.2018.07.003_bib0520","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2018.07.003_bib0525","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM200205093461911","article-title":"Pheochromocytoma\u2014death of an axiom","volume":"346","author":"Dluhy","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2018.07.003_bib0530","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.2006.02714.x","article-title":"Phaeochromocytoma, new genes and screening strategies","volume":"65","author":"Gimenez-Roqueplo","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2018.07.003_bib0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MED.0000000000000150","article-title":"Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes","volume":"22","author":"Toledo","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.lpm.2018.07.003_bib0540","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"NGS in PPGL (NGSnPPGL) Study Group","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0545","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CCO.0000000000000249","article-title":"Pheochromocytoma and paraganglioma: molecular testing and personalized medicine","volume":"28","author":"Burnichon","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.lpm.2018.07.003_bib0550","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0555","first-page":"107","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2018.07.003_bib0560","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0565","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted exome sequencing of Krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0570","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2018.07.003_bib0575","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0580","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0585","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1210\/en.2011-0052","article-title":"Minireview: the busy road to pheochromocytomas and paragangliomas has a new member, TMEM127","volume":"152","author":"Jiang","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.lpm.2018.07.003_bib0590","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casc\u00f3n","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0595","doi-asserted-by":"crossref","first-page":"E805","DOI":"10.1210\/jc.2011-3360","article-title":"TMEM127 screening in a large cohort of patients with pheochromocytoma and\/or paraganglioma","volume":"97","author":"Abermil","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0600","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0605","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00439-008-0553-1","article-title":"A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors","volume":"124","author":"Yeh","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0610","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0615","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2018.07.003_bib0620","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-M\u00e9ndez","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2018.07.003_bib0625","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome","volume":"99","author":"Buffet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.07.003_bib0630","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-0032-1311568","article-title":"Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation","volume":"44","author":"Lahlou-Lafor\u00eat","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.lpm.2018.07.003_bib0635","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.lpm.2018.07.003_bib0640","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driven tumorigenesis: from genetics to targeted therapy","volume":"135","author":"Morin","year":"2014","journal-title":"Int J Cancer"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218302860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218302860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T02:05:41Z","timestamp":1535594741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218302860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":64,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0755498218302860"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.07.003","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma: When to search a germline defect?","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}